title: Evaluation of the antiviral effect of rifabutin in AIDS-related complex.
authors.affiliation: Stanford University School of Medicine, CA 94305.
authors.forename: J
authors.initials: J
authors.lastname: Torseth
authors.forename: G
authors.initials: G
authors.lastname: Bhatia
authors.forename: S
authors.initials: S
authors.lastname: Harkonen
authors.forename: C
authors.initials: C
authors.lastname: Child
authors.forename: M
authors.initials: M
authors.lastname: Skinner
authors.forename: W S
authors.initials: WS
authors.lastname: Robinson
authors.forename: T F
authors.initials: TF
authors.lastname: Blaschke
authors.forename: T C
authors.initials: TC
authors.lastname: Merigan
mesh_terms: D000386:AIDS-Related Complex / Q000188:drug therapy*; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006678:HIV / Q000187:drug effects*; D015488:HIV Antigens / Q000032:analysis; D016655:HIV Core Protein p24; D006801:Humans; D008297:Male; D012191:Retroviridae Proteins / Q000032:analysis; D017828:Rifabutin; D012294:Rifamycins / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D015488:HIV Antigens; D016655:HIV Core Protein p24; D012191:Retroviridae Proteins; D012294:Rifamycins; D017828:Rifabutin